Recently the Chengdu Hi-tech Industrial Development Zone (Chengdu Hi-tech Zone) and Singapore-Sichuan Hi-tech Innovation Park (SSCIP) held a signing ceremony for official cooperation agreements with five partners — Singapore Hong Leong Group ; Beijing TRS Information Technology Co., Ltd. ; Sichuan Good Doctor Pharmaceutical Group ; Nanjing Sample Technology Group Co., Ltd. ; Sichuan Aipu Network Co., Ltd. — and a total investment of 3.73 billion RMB. It is the second batch of key projects settling down in SSCI P this year.

Since the ground-breaking in May 2012, the progress and development of SSCIP has been tremendous. It is known as another landmark of the collaboration between China and Singapore. On Feb. 27, Shenzhen Power Leader Group, Guangdong OPPO Mobile Telecommunications Corporation, and Guangxi Conha Group announced a 6.7 billion RMB investment in the park. This means that by early July of 2014, through the platform of SSCIP, Chengdu has obtained over 10 Billion RMB in investments.

Under China’s efforts to speed up the comprehensive reform and building of the Silk Road economic belt, the importance of west China as a hinterland is increasing ly highlighted. Chengdu Hi-tech Zone, where SSCIP is located, is actively drafting its Negative List, and carrying out regular promotions for global investment while helping local companies “go overseas” to expand their business es. Meanwhile, the 9th EU-China Business & Technology Cooperation Fair will be hel d this autumn in Chengdu Hi-tech Zone, offering more opportunities for international cooperation.

“The park is going to America for investment promotion s next month. We will set up our very first overseas office beyond East Asia in San Francisco. The office will target the bio-medical, IT and digital media industries of the states,” said Cui Wei, CEO of Sino-Singapore ( Chengdu) Innovation Park Development Co ., Ltd .